期刊文献+

抗精神病药物治疗的“三五”原则 被引量:2

“Triple-five”principles of antipsychotic treatment
下载PDF
导出
摘要 “三五”原则是指:(1)选药的“五要”原则,即有效、安全、便宜、方便及易换;(2)确保安全的“五不要”守则,即避免锥体外症候群、高催乳素血症、并用抗精神病药物、与抗胆碱能药物联用及体重增加;(3)必须停药(或换药)的5种最“要不得”意外,即抗精神病药物恶性症候群、粒性白血球缺乏症、急性心肌炎、心室性传导障碍及新发Ⅱ型糖尿病。 This article reviews guidelines for the choice of antipsychotics in the treatment of schizophrenia. At least five major factors are essential for the consideration in clinical practice. These include efficacy, adverse reactions, costs, convenience of use and easy to switch. Moreover, five important safety considerations which should be emphasized in the selection and use of first-line atypical antipsychotics are listed as follows: (1) to avoid extrapyramidal symptoms; (2) to avoid hyperprolactinemia; (3) to avoid antipsychotic polypharmacy; (4) to avoid anticholinergic medication; and (5) to avoid weight gain. In addition, five serious adverse reactions may require switching to an alternative agent. These include: (1) neuroleptic malignant syndrome; (2) agranulocytosis; (3) myocarditis; (4) cardiac rhythm abnormalities; and (5) impaired glucose tolerance.
作者 张文和
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2006年第8期619-624,共6页 Chinese Journal of New Drugs and Clinical Remedies
关键词 精神分裂症 抗精神病药物 药物疗法 选药原则 药物不良反应 schizophrenia antipsychotic agents drug therapy drug choice adverse drug reactions
  • 相关文献

参考文献21

  • 1SARTORIUS N, FLEISCHHACKER WW, GJERRIS A, et al.The usefulness and use of second-generation antipsychotic medications[J]. Curr Opin Psychiatry, 2003, 16 (Suppl 1):S 1-S 44.
  • 2JESTE DV, PARMER BW, HARRIS MJ. Neuroleptic discontinuation in clinical and research settings: scientific issues and ethical dilemmas[J]. Biol Psychiatry, 1999, 46 (8): 1050-1059.
  • 3GEDDES J, FREEMANTLE N, HARRISON P, et al. Atypical antipsychotics in the treatment of schizophrenia:systematic overview and meta-regression analysis[J]. BMJ, 2000, 321 (7273) :1371-1376.
  • 4THOMAS CS, LEVIS S. Which atypical antipsychotic? [J]. Br J Psychiatry, 1998, 172 (2): 106-109.
  • 5张文和.建议推行规范化药物治疗(编者评论)[J].台湾精神医学,2001,15(2):85-85.
  • 6DAVIS JM, CHEN N, GLICH I. A meta-analysis of the efficacy of second-generation antipsychotics[J]. Arch Gen Psychiatry,2003, 60 (6): 553-564.
  • 7OHLSEN R, SMITH S, TAYLOR D, et al. The maudsley antipsychotic medication review service guidelines [M], London:Martin Dunitz, 2003.
  • 8CASTLE D, ALDERTON D. Psychopharmacological management of schizophrenia[M]//CASTLE D, COPOLOV D, WYKES T. Pharmacological and psychosocial treatments in schizophrenia.London: Martin Dunitz, 2003.1-22.
  • 9American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes [J].J Clin Psychiatry, 2004, 65 (2): 267-272.
  • 10FONTAINE KR, HEO M, HARRIGAN EP, et al. Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate[J]. Psychiatry Res, 2001, 101 (3) :277-288.

二级参考文献2

  • 1矯汉勤.氯氮平致精神障碍[J]山东精神医学,1988(01).
  • 2孙德麒.氯氮平戒断反应1例报告[J]中国神经精神疾病杂志,1987(03).

共引文献4

同被引文献6

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部